Evidence map›Paper›PMID 39060412›Full record

ArticleScientific reports2024

Comparative network-based analysis of toll-like receptor agonist, L-pampo signaling pathways in immune and cancer cells.

Sera Park, Geuntae Kim, Ahyoung Choi, Sun Kim, Jung Sun Yum, Eunyoung Chun, Hyunjin Shin

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sera ParkMOGAM Institute for Biomedical Research, Seoul, 06730, Republic of Korea.
Geuntae KimCHA Vaccine Institute, Seongnamsi, Gyenggido, 13488, South Korea.
Ahyoung ChoiMOGAM Institute for Biomedical Research, Seoul, 06730, Republic of Korea.
Sun KimMOGAM Institute for Biomedical Research, Seoul, 06730, Republic of Korea.
Jung Sun YumCHA Vaccine Institute, Seongnamsi, Gyenggido, 13488, South Korea.
Eunyoung ChunCHA Vaccine Institute, Seongnamsi, Gyenggido, 13488, South Korea. echun@chamc.co.kr.
Hyunjin ShinMOGAM Institute for Biomedical Research, Seoul, 06730, Republic of Korea. hyunjin.shin@mogam.re.kr.

Funding

Ministry of Trade, Industry and Energy 20014948
6 · The paper itself

Abstract

Toll-like receptors (TLRs) are critical components to stimulate immune responses against various infections. Recently, TLR agonists have emerged as a promising way to activate anti-tumor immunity. L-pampo, a TLR1/2 and TLR3 agonist, induces humoral and cellular immune responses and also causes cancer cell death. In this study, we investigated the L-pampo-induced signals and delineated their interactions with molecular signaling pathways using RNA-seq in immune cells and colon and prostate cancer cells. We first constructed a template network with differentially expressed genes and influential genes from network propagation using the weighted gene co-expression network analysis. Next, we obtained perturbed modules using the above method and extracted core submodules from them by conducting Walktrap. Finally, we reconstructed the subnetworks of major molecular signals utilizing a shortest path-finding algorithm, TOPAS. Our analysis suggests that TLR signaling activated by L-pampo is transmitted to oxidative phosphorylation (OXPHOS) with reactive oxygen species (ROS) through PI3K-AKT and JAK-STAT only in immune and prostate cancer cells that highly express TLRs. This signal flow may further sensitize prostate cancer to L-pampo due to its high basal expression level of OXPHOS and ROS. Our computational approaches can be applied for inferring underlying molecular mechanisms from complex gene expression profiles.

Indexed as

Gene Regulatory NetworksSignal TransductionToll-Like ReceptorsCell Line, TumorHumansMaleOxidative PhosphorylationProstatic NeoplasmsReactive Oxygen SpeciesToll-Like Receptor AgonistsReactive Oxygen SpeciesToll-Like Receptor AgonistsToll-Like Receptors

Identifiers

PMID39060412
PMCPMC11282102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.